SEC Filings

Form 10-K
MICROBOT MEDICAL INC. filed this Form 10-K on 04/01/2019
Document Outline
Entire Document (3436.6 KB)
Subdocument 1 - 10-K
Page 1 - UNITED STATES
Page 2 - Table of Contents
Page 3 - PART I
Page 4 - Industry Overview
Page 5 - Our Product Pipeline
Page 6 - N/A
Page 7 - Strategy
Page 8 - Intellectual Property
Page 9 - License Agreement with the Technion
Page 10 - Manufacturing
Page 11 - Government Regulation
Page 12 - N/A
Page 13 - N/A
Page 14 - Europe. The primary regulatory body in Europe is the European Union, or E.U., which consists of 28 m
Page 15 - Employees
Page 16 - Risks Relating to Microbot s Financial Position and Need for Additional Capital
Page 17 - Raising additional capital may cause dilution to the Company s investors, restrict its operations or
Page 18 - Risks Relating to the Development and Commercialization of Microbot s Product Candidates
Page 19 - At this time, Microbot does not know whether the FDA will require it to submit clinical data in supp
Page 20 - Unsuccessful animal studies, clinical trials or procedures relating to product candidates under deve
Page 21 - Customers will be unlikely to buy the SCS unless Microbot can demonstrate that they can be produced
Page 22 - Microbot may be subject to penalties and may be precluded from marketing its product candidates if M
Page 23 - Clinical outcome studies for the SCS may not provide sufficient data to make Microbot s product cand
Page 24 - Our business strategy in part relies on identifying, acquiring and developing complementary technolo
Page 25 - Microbot operations in international markets involve inherent risks that Microbot may not be able to
Page 26 - Microbot may not meet its product candidates development and commercialization objectives in a timel
Page 27 - Dependence on patent and other proprietary rights and failing to protect such rights or to be succes
Page 28 - Exchange rate fluctuations between the U.S. dollar and the NIS currencies may negatively affect Micr
Page 29 - Risks Relating to Microbot s Securities, Governance and Other Matters
Page 30 - The issuance of shares upon exercise of outstanding warrants and options could cause immediate and s
Page 31 - Sabby Litigation
Page 32 - PART II
Page 33 - Item 6. Selected Financial Data.
Page 34 - Financial Operations Overview
Page 35 - Fair Value of Financial Instruments
Page 36 - Liquidity and Capital Resources
Page 37 - Cash Flows
Page 38 - Item 9A. Controls and Procedures.
Page 39 - N/A
Page 40 - Executive Officers
Page 41 - Director Oversight and Qualifications
Page 42 - Item 11. Executive Compensation.
Page 43 - Harel Gadot Employment Agreement
Page 44 - David Ben Naim Services Agreement
Page 45 - Item 12. Security Ownership of Certain Beneficial Owners and Management and Related Stockholder Matt
Page 46 - Item 13. Certain Relationships and Related Transactions, and Director Independence.
Page 47 - Pre-Approval Policies and Procedures
Page 48 - N/A
Page 49 - SIGNATURES
Page 50 - MICROBOT MEDICAL INC.
Page 51 - REPORT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
Page 52 - MICROBOT MEDICAL INC.
Page 53 - MICROBOT MEDICAL INC.
Page 54 - MICROBOT MEDICAL INC.
Page 55 - MICROBOT MEDICAL INC.
Page 56 - MICROBOT MEDICAL INC.
Page 57 - MICROBOT MEDICAL INC.
Page 58 - MICROBOT MEDICAL INC.
Page 59 - MICROBOT MEDICAL INC.
Page 60 - MICROBOT MEDICAL INC.
Page 61 - MICROBOT MEDICAL INC.
Page 62 - MICROBOT MEDICAL INC.
Page 63 - MICROBOT MEDICAL INC.
Page 64 - MICROBOT MEDICAL INC.
Page 65 - MICROBOT MEDICAL INC.
Page 66 - MICROBOT MEDICAL INC.
Page 67 - MICROBOT MEDICAL INC.
Page 68 - MICROBOT MEDICAL INC.
Page 69 - MICROBOT MEDICAL INC.
Page 70 - MICROBOT MEDICAL INC.
Page 71 - MICROBOT MEDICAL INC.
Page 72 - MICROBOT MEDICAL INC.
Page 73 - N/A
Subdocument 2 - EX-31.1 - Certifications required under Section 302 of the Sarbanes-Oxley Act of 2002
Page 1 - Exhibit 31.1
Page 2 - N/A
Subdocument 3 - EX-31.2 - Certifications required under Section 302 of the Sarbanes-Oxley Act of 2002
Page 1 - Exhibit 31.2
Page 2 - N/A
Subdocument 4 - EX-32.1 - Certifications required under Section 906 of the Sarbanes-Oxley Act of 2002
Page 1 - Exhibit 32.1
Page 2 - N/A
Subdocument 5 - EX-32.2 - Certifications required under Section 906 of the Sarbanes-Oxley Act of 2002
Page 1 - Exhibit 32.2
Page 2 - N/A
XBRL Item - EX-101.INS - XBRL INSTANCE FILE (What's this?)
XBRL Item - EX-101.SCH - XBRL SCHEMA FILE (What's this?)
XBRL Item - EX-101.CAL - XBRL CALCULATION FILE (What's this?)
XBRL Item - EX-101.DEF - XBRL DEFINITION FILE (What's this?)
XBRL Item - EX-101.LAB - XBRL LABEL FILE (What's this?)
XBRL Item - EX-101.PRE - XBRL PRESENTATION FILE (What's this?)
XBRL Viewer